Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia

Phase III Study Priming With rhu_GM-CSF and of Three Induction Regimens in Adult Patients (55 and Over) With Acute Non-Lymphocytic Leukemia

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04446052

Enrollment

362

Registered

2020-06-24

Start date

1993-05-21

Completion date

2002-07-10

Last updated

2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia

Brief summary

Phase III Study of Priming with Granulocyte-Macrophage Colony Stimulating Factor (rhu-GM-CSF) and ofThree Induction Regimens in Adult Patients (Over 55) with Acute Non-Lymphocytic Leukemia

Interventions

DRUGGM-CSF priming

DRUGPlacebo

Placebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

56 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients with acute non-lymphocytic leukemia are eligible for the study.

Exclusion criteria

* N/A

Design outcomes

Primary

Measure	Time frame
complete remission rates	3 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026